Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 18Unknown 6Terminated 4Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 11Lymphoid 11Other hematologic neoplasm 4Genitourinary 4Plasma cell 1Gynecologic 1CNS 1

Conditions

Neuroblastoma 1

Interventions

Temozolomide 78Magnetic Resonance Spectroscopy 69Specimen Handling 45Radiotherapy 42Bevacizumab 28Radiosurgery 27Cyclophosphamide 27Radiation 20pembrolizumab 19Blood Specimen Collection 19fludarabine 16Nivolumab 16Irinotecan 14Carboplatin 13Biopsy 13Etoposide 12Vincristine 11Pemetrexed 11Lomustine 11Surgical Procedures, Operative 9trametinib 8dinutuximab 8abemaciclib 8Ipilimumab 8Fluorodeoxyglucose F18 8naxitamab 7fluciclovine F-18 7Watchful Waiting 7Topotecan 7Proton Therapy 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Ifosfamide × CNS × Clear all
NCT06528496 2026-02-10

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
45 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡